Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 26;42(12):113431.
doi: 10.1016/j.celrep.2023.113431. Epub 2023 Nov 30.

Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD

Affiliations
Free article

Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD

Shin-Ichi Mae et al. Cell Rep. .
Free article

Abstract

In autosomal dominant polycystic kidney disease (ADPKD), renal cyst lesions predominantly arise from collecting ducts (CDs). However, relevant CD cyst models using human cells are lacking. Although previous reports have generated in vitro renal tubule cyst models from human induced pluripotent stem cells (hiPSCs), therapeutic drug candidates for ADPKD have not been identified. Here, by establishing expansion cultures of hiPSC-derived ureteric bud tip cells, an embryonic precursor that gives rise to CDs, we succeed in advancing the developmental stage of CD organoids and show that all CD organoids derived from PKD1-/- hiPSCs spontaneously develop multiple cysts, clarifying the initiation mechanisms of cystogenesis. Moreover, we identify retinoic acid receptor (RAR) agonists as candidate drugs that suppress in vitro cystogenesis and confirm the therapeutic effects on an ADPKD mouse model in vivo. Therefore, our in vitro CD cyst model contributes to understanding disease mechanisms and drug discovery for ADPKD.

Keywords: CP: Stem cell research; autosomal dominant polycystic kidney disease; collecting duct; high-throughput screening; human induced pluripotent stem cell; in vitro model; organoid; ureteric bud.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.-I.M. is a scientific advisor of Rege Nephro Co., Ltd. K.O. is a founder and member of the scientific advisory boards of iPS Portal, Inc., and a founder and chief scientific advisor of Rege Nephro Co., Ltd. S.-I.M., M.R., and K.O. are the inventors of Japanese patent no. 7162349.

Publication types

Substances

Supplementary concepts